StockData
Amgen Inc logo

Amgen Inc (AMGN) operating KPIs

AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)

Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%

Amgen total Product Sales — Worldwide volume growth YoY (%) (%)

Form 8-K Key Results & Form 10-Q / 10-K MD&A

Latest, Q1 2026
9.0%
Period ended Mar 31, 2026
Change on a year earlier
-5.0 pts
14.0% in Q1 2025
History
11 quarters
Since Q1 2020
Sources
11
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Cite this data

StockData. (2026). Amgen Total Product Sales — Worldwide volume growth YoY (%) (%), quarterly Q1 2020–Q1 2026 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/prod_total_vol

See every metric in the Amgen KPI table. Data updated Oct 28, 2026.